Long ‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab

Journal of the European Academy of Dermatology and Venereology,Volume 0, Issue ja, -Not available-.

Source: Journal of the European Academy of Dermatology and Venereology - October 16, 2018 Category: Dermatology Authors: Y. Umezawa, H. Torisu ‐Itakura, Y. Morisaki, H. ElMaraghy, K. Nakajo, N. Akashi, H. Saeki, The Japanese Ixekizumab Study Group Source Type: research